Measuring CCL3L1 Copy Number in Autoimmune Disorders
Author Information
Author(s): Danielle Carpenter, Susan Walker, Natalie Prescott, Joost Schalkwijk, John Armour
Primary Institution: Centre for Genetics and Genomics, University of Nottingham
Hypothesis
Can accurate measurement of CCL3L1 copy number reveal associations with autoimmune disorders?
Conclusion
The study found no association between CCL3L1 copy number and the autoimmune disorders Crohn's disease, rheumatoid arthritis, or psoriasis.
Supporting Evidence
- The PRT method showed high accuracy in measuring copy number.
- No significant association was found between CCL3L1 copy number and the studied autoimmune disorders.
- Differential bias was resolved by pre-treatment with restriction enzyme digestion.
Takeaway
The researchers looked at a gene related to immune response and found that its copy number doesn't seem to affect certain diseases.
Methodology
The study used a modified paralogue ratio test (PRT) to measure CCL3L1/CCL4L1 copy number in European samples.
Potential Biases
Differential bias was observed in one cohort, potentially affecting results.
Limitations
The study may lack power to detect smaller effects due to sample size.
Participant Demographics
The study included 1581 European samples from patients with Crohn's disease, rheumatoid arthritis, and psoriasis.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website